comparemela.com

Latest Breaking News On - Jamal al kaabi - Page 10 : comparemela.com

Emirates News Agency - DoH announces classification results of distinguished healthcare facilities for 2019

DoH announces classification results of distinguished healthcare facilities for 2019 ABU DHABI, 21st December, 2020 (WAM) The Department of Health – Abu Dhabi (DoH) announced that following an evaluation based on the Abu Dhabi Healthcare Quality Index ‘Muashir’, no fewer than 44 healthcare facilities in Abu Dhabi received a rating of between two and five diamonds. This classification reflects DoH’s commitment to maintaining excellence in providing innovative healthcare services in line with international quality standards, helping to elevate the patient experience and achieve the highest levels of satisfaction. According to the Muashir Quality Index, two healthcare facilities were awarded five diamonds for their performance in 2019, which counts as Outstanding; five healthcare facilities were ranked as Exceptional with a four diamond rating; 31 health facilities were adjudged to be Excellent with a score of three diamonds; and six health facilities achieved the Very Good

COVID-19: Abu Dhabi Hope Consortium expands its offering through four major partnerships

Abu Dhabi: The newly-launched Hope Consortium, a UAE-based public-private partnership, has bolstered its distribution reach following a strategic agreement with leading international freight forwarders. The latest consortium partners, which include Agility, Aramex, Hellmann and Kuehne + Nagel, will help address the different steps of the logistical challenge, including the ‘last mile’ challenge, with a capacity of billions of SARS-CoV-2 vaccine doses by the end of 2021. Spearheaded by the Department of Health Abu Dhabi (DoH), the Hope Consortium appointed these global transport companies based on their expert abilities and reach to safely and effectively deliver vaccine doses under cold and ultra-cold conditions temperature bands 2-8 degrees Celsius, -20 degrees Celsius and -80 degrees Celsius between transportation hubs, warehouses, medical facilities and other final destinations in over 170 countries.

What We Know About China s Vaccine

The United Arab Emirates (UAE) has approved a vaccine from a Chinese drugmaker. Almost 100,000 people across the UAE have received the vaccine as part of a voluntary program. All data and statistics are based on publicly available data at the time of publication. Some information may be out of date. Visit our coronavirus hub and follow our live updates page for the most recent information on the COVID-19 pandemic. The United Arab Emirates approved the Chinese drugmaker Sinopharm’s COVID-19 vaccine candidate, the country’s Ministry of Health and Prevention (MOHAP) announced Dec. 9. According to the official press release, this vaccine has been granted emergency use authorization in the United Arab Emirates (UAE) since September to “protect frontline workers most at risk of COVID-19.”

China s Sinopharm vaccine: how effective is it and where will it be rolled out?

China s Sinopharm Covid vaccine: how effective is it and where will it be rolled out? Helen Davidson © Provided by The Guardian Photograph: Tingshu Wang/Reuters Trials in the United Arab Emirates have shown that China’s Sinopharm vaccine has 86% efficacy. So what is the Chinese treatment, where is it being trialled and will it challenge the vaccines being developed in western countries? © Photograph: Tingshu Wang/Reuters Sinopharm is a state-owned Chinese pharmaceutical company and is trialling two Covid-19 vaccines in countries including UAe, Argentina and Morocco. What is the Sinopharm vaccine? Sinopharm Group is a state-owned pharmaceutical company with two vaccine candidates among China’s five experimental treatment in international final stage trials. The vaccines are not being trialled in China because the domestic prevalence of the virus is so low. Sinopharm’s vaccine and bioscience subsidiary is the China National Biotec Group Co Ltd (CNB

China s Sinopharm Covid vaccine: how effective is it and where will it be rolled out?

China s Sinopharm Covid vaccine: how effective is it and where will it be rolled out? Helen Davidson © Provided by The Guardian Photograph: Tingshu Wang/Reuters Trials in the United Arab Emirates have shown that China’s Sinopharm vaccine has 86% efficacy. So what is the Chinese treatment, where is it being trialled and will it challenge the vaccines being developed in western countries? © Photograph: Tingshu Wang/Reuters Sinopharm is a state-owned Chinese pharmaceutical company and is trialling two Covid-19 vaccines in countries including UAe, Argentina and Morocco. What is the Sinopharm vaccine? Sinopharm Group is a state-owned pharmaceutical company with two vaccine candidates among China’s five experimental treatment in international final stage trials. The vaccines are not being trialled in China because the domestic prevalence of the virus is so low. Sinopharm’s vaccine and bioscience subsidiary is the China National Biotec Group Co Ltd (CNB

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.